Literature DB >> 15526551

Neuronal structure is altered by amyloid plaques.

Tara L Spires1, Bradley T Hyman.   

Abstract

During the course of Alzheimer's disease (AD), neurons undergo extensive remodeling, contributing to the loss of function observed in the disease. Many brain regions in patients with AD show changes in axonal and dendritic fields, dystrophic neurites, synapse loss, and neuron loss. Accumulation of amyloid-beta protein, a pathological hallmark of the disease, contributes to many of these alterations of neuronal structure. Areas of the brain displaying a high degree of plasticity are particularly vulnerable to degeneration in Alzheimer's disease. This article describes neuronal changes that occur in AD, reviews evidence that amyloid-beta contributes to these changes, and finally discusses the recovery of amyloid-induced changes in the brains of transgenic mice, lending hope to the idea that therapeutic strategies which reduce amyloid-beta production will lead to functional recovery in patients with AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526551     DOI: 10.1515/revneuro.2004.15.4.267

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  43 in total

1.  Morphofunctional changes in goldfish Mauthner neurons after application of beta-amyloid.

Authors:  N A Kokanova; G Z Mikhailova; R Sh Shtanchaev; N R Tiras; E N Bezgina; D A Moshkov
Journal:  Neurosci Behav Physiol       Date:  2010-08-04

Review 2.  The upside of APP at synapses.

Authors:  Hyang-Sook Hoe; Hey-Kyoung Lee; Daniel T S Pak
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

3.  Morphological Bases of Neuronal Hyperexcitability in Neurodegeneration.

Authors:  Ti-Fei Yuan; Bo Peng; Sergio Machado; Oscar Arias-Carrion
Journal:  CNS Neurosci Ther       Date:  2015-11       Impact factor: 5.243

Review 4.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

Review 5.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

6.  Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease.

Authors:  J Steven Jacobsen; Chi-Cheng Wu; Jeffrey M Redwine; Thomas A Comery; Robert Arias; Mark Bowlby; Robert Martone; John H Morrison; Menelas N Pangalos; Peter H Reinhart; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

Review 7.  Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease.

Authors:  Suzanne E Hickman; Joseph El Khoury
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-04       Impact factor: 4.388

8.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 9.  Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B.

Authors:  Keith A Johnson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

10.  Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy.

Authors:  Tara L Spires; Melanie Meyer-Luehmann; Edward A Stern; Pamela J McLean; Jesse Skoch; Paul T Nguyen; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.